When is surgical therapy indicated for bronchiectasis?

When is surgical therapy indicated for bronchiectasis?

• A. After failure of medical therapy, especially with persistent hemoptysis or infection
• B. Immediately on diagnosis
• C. In all cases regardless of symptoms
• D. Only in pediatric patients

Answer: (A)

Surgical therapy for bronchiectasis is considered when the disease is localized and medical management has failed, especially if there is ongoing hemoptysis or recurrent infections. The idea is to remove the diseased portion of the lung that perpetuates infection and bleeding, breaking the cycle of inflammation and allowing better airway clearance and function. This approach works best when imaging shows a well-demarcated area of bronchiectasis (often in one lobe or segment) and the patient has adequate overall lung reserve to tolerate resection. Before deciding on surgery, careful evaluation is done to map the diseased area, assess lung function, and ensure infection is controlled as much as possible. If disease is diffuse or bilateral, or pulmonary reserve is poor, surgery is not favored and medical therapy or other options are pursued. If a patient has persistent symptoms despite optimized medical therapy—such as recurrent infections requiring hospitalization or antibiotics, or troublesome bleeding that cannot be controlled conservatively—surgical removal of the affected segment or lobe can be warranted. Pediatric patients may be considered in selected cases, but the principle remains the same: reserve surgery for localized disease after medical therapy has been maximized. So, the best answer is: after failure of medical therapy, especially with persistent hemoptysis or infection, provided the disease is localized and the patient can tolerate resection.

Surgical therapy for bronchiectasis is considered when the disease is localized and medical management has failed, especially if there is ongoing hemoptysis or recurrent infections. The idea is to remove the diseased portion of the lung that perpetuates infection and bleeding, breaking the cycle of inflammation and allowing better airway clearance and function. This approach works best when imaging shows a well-demarcated area of bronchiectasis (often in one lobe or segment) and the patient has adequate overall lung reserve to tolerate resection.

Before deciding on surgery, careful evaluation is done to map the diseased area, assess lung function, and ensure infection is controlled as much as possible. If disease is diffuse or bilateral, or pulmonary reserve is poor, surgery is not favored and medical therapy or other options are pursued.

If a patient has persistent symptoms despite optimized medical therapy—such as recurrent infections requiring hospitalization or antibiotics, or troublesome bleeding that cannot be controlled conservatively—surgical removal of the affected segment or lobe can be warranted. Pediatric patients may be considered in selected cases, but the principle remains the same: reserve surgery for localized disease after medical therapy has been maximized.

So, the best answer is: after failure of medical therapy, especially with persistent hemoptysis or infection, provided the disease is localized and the patient can tolerate resection.